Kager, LeoWhelan, JeremyDirksen, UtaHassan, BassAnninga, JakobBennister, LindseyBovée, Judith V M GBrennan, BernadetteBroto, Javier MBrugières, LaurenceCleton-Jansen, Anne-MarieCopland, ChristopherDutour, AurélieFagioli, FrancaFerrari, StefanoFiocco, MartaFleuren, EmmyGaspar, NathalieGelderblom, HansGerrand, CraigGerß, JoachimGonzato, Ornellavan der Graaf, WinetteHecker-Nolting, StefanieHerrero-Martín, DavidKlco-Brosius, StephanieKovar, HeinrichLadenstein, RuthLancia, CarloLeDeley, Marie-CecileMcCabe, Martin GMetzler, MarkusMyklebost, OlaNathrath, MichaelaPicci, PieroPotratz, JennyRedini, FrançoiseRichter, Günther H SReinke, DeniseRutkowski, PiotrScotlandi, KatiaStrauss, SandraThomas, DavidTirado, Oscar MTirode, FranckVassal, GillesBielack, Stefan S2025-01-072025-01-072016-03-162045-3329https://hdl.handle.net/10668/27772This report summarizes the results of the 3rd Joint ENCCA-WP7, EuroSarc, EEC, PROVABES, and EURAMOS European Bone Sarcoma Network Meeting, which was held at the Children's Cancer Research Institute in Vienna, Austria on September 24-25, 2015. The joint bone sarcoma network meetings bring together European bone sarcoma researchers to present and discuss current knowledge on bone sarcoma biology, genetics, immunology, as well as results from preclinical investigations and clinical trials, to generate novel hypotheses for collaborative biological and clinical investigations. The ultimate goal is to further improve therapy and outcome in patients with bone sarcomas.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Bone sarcomaEwing sarcomaImmunotherapyNext generation sequencingOsteosarcomaPharmacogenomicsTranslational researchresearch article27315524open access10.1186/s13569-016-0043-5PMC4794847https://clinicalsarcomaresearch.biomedcentral.com/counter/pdf/10.1186/s13569-016-0043-5https://pmc.ncbi.nlm.nih.gov/articles/PMC4794847/pdf